Jon McDunn

Jon is a biotechnology entrepreneur (Combion, Incyte Genomics, Metabolon, and Clinical Sensors). During his career, Jon has invented tools, techniques, and processes for bioanalysis and therapeutic delivery. His current company, Clinical Sensors, is developing a point of care assay for use in the intensive care unit to identify patients that are developing sepsis. Clinical Sensors has been awarded over $4M from the National Institutes of Health for this work. Jon has published 50 biomedical research papers and is an inventor on 2 issued patents. He received his BS in Chemistry from Caltech, his PhD in Inflammation Biology from The Scripps Research Institute, and postdoctoral training in Critical Care Medicine from Washington University School of Medicine. Jon has held faculty positions at both Washington University and the University of North Carolina at Chapel Hill.